# Aizant Drug Research Solutions Private Ltd. – FDA Inspection, Jan 25, 2023

Source: https://www.keypedia.com/records/fda_inspections/aizant-drug-research-solutions-private-ltd/1eb2ba96-2b19-4f06-b949-790c52fd48c8
Source feed: FDA_Inspections

> FDA inspection 1198206 of Aizant Drug Research Solutions Private Ltd., January 25, 2023. Classification: No Action Indicated (NAI). 9 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1198206
- Company Name: Aizant Drug Research Solutions Private Ltd.
- Inspection Date: 2023-01-25
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1328790 - 2026-07-31](https://www.keypedia.com/records/fda_inspections/aizant-drug-research-solutions-private-ltd/a86deacc-188a-4bf6-9acd-c068a644fc12)
- [FDA Inspection 1301216 - 2025-11-14](https://www.keypedia.com/records/fda_inspections/aizant-drug-research-solutions-private-ltd/4f556e06-b94d-4f83-9f09-8d15e4234cc0)
- FDA Inspection 1207686 - 2023-04-28
- [FDA Inspection 1115743 - 2020-01-24](https://www.keypedia.com/records/fda_inspections/aizant-drug-research-solutions-private-ltd/5683187f-016a-4857-bf2c-f553475a8680)
- FDA Inspection 1095186 - 2019-05-03

## Related Officers

- [Company Rep](https://www.keypedia.com/people/sheri-l-stephenson/dd4f3755-bb3b-4a14-a08f-8d59fbb0b6fa)

Company: https://www.keypedia.com/companies/aizant-drug-research-solutions-private-ltd/1a2d8dae-2eb4-4bc8-b36b-e94775bccd50

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
